Drug intelligence / Profile preview

Eperisone hydrochloride + diclofenac sodium

Development stage
Unknown
Lead developer
Eisai
Modality
Small Molecules
Administration
Oral
01

Overview

Eperisone hydrochloride + diclofenac sodium is a fixed-dose combination of two pharmaceutical agents used primarily for the management of acute musculoskeletal pain and muscle spasms, especially in conditions such as low back pain. Eperisone is a centrally acting muscle relaxant (antispasmodic) that works by relaxing skeletal muscles and vascular smooth muscles, reducing myotonia, improving blood circulation, and suppressing the pain reflex. Its mechanism involves inhibition of neural activity and pain sensation by blocking voltage-gated sodium channels in the brain stem[3][7]. Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID) that exerts its effect mainly through inhibition of cyclooxygenase (COX), thereby reducing prostaglandin synthesis responsible for inflammation and pain[1][2][6]. The combination provides synergistic relief from both muscle spasm-related stiffness and inflammatory pain. This product is not approved in all countries but is widely available in India and other Asian markets.

Brand names
Rapisone-DEpriprideEprisan DEperifenEpry DEpridol-DEprinak-E DEprimatEprilocEpisron D
Other names
eperisone + diclofenac
02

Targets

NaV (Voltage-gated sodium channels)COXCaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on Eperisone hydrochloride + diclofenac sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eperisone hydrochloride + diclofenac sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call